CloudMD Software and Services Inc. (DOCRF)

[StockpickerCAPC]

Digital Transformation of Healthcare: Leaders of CloudMD Driving Explosive Revenue Growth with Innovation and M&A.

source
https://finance.yahoo.com/news/digital-transformation-healthcare-leaders-cloudmd-133600818.html

Wall Street Reporter
Tue, June 29, 2021, 3:36 PM

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at CloudMD (OTC: DOCRF) (TSX.V: DOC).

CloudMD CEO, Dr. Essam Hamza: “CloudMD: The Future of Healthcare Is Here - NOW”
CloudMD CEO Dr. Essam Hamza, M.D. shared with Wall Street Reporter’s investor audiences how CloudMD is addressing a multi-billion dollar market opportunity by digitizing the delivery of healthcare, with a focus on “whole persons health” - including mental health - providing patients access to all points of their care from their phone, tablet or desktop computer. DOCRF closed out 2020 with a series of blockbuster acquisitions and flush with cash from oversubscribed capital raises, positioned for its next exciting growth phase.

Sharing his vision for DOCRF in 2021, CEO Dr. Essam Hamza said: “The growth of 2020 was just a preview for what’s to come... Now that we have the team, infrastructure, and capital in place, we are ready for the real growth phase. 2021 will be the real inflection point for CloudMD - and we are just getting started... ”

June 28 - DOCRF announces closing acquisition of Oncidium Inc., one of Canada’s leading healthcare providers to employers. Oncidium has built a difficult-to-replicate ecosystem of over 500 clients servicing more than 2 million employees across Canada and more than 2,000 health care providers and medical assessors. Oncidium has an annualized revenue run rate of $54 million with an Adjusted EBITDA margin of 10%, is highly accretive to CloudMD. On a consolidated basis, CloudMD has an annualized revenue run rate of approximately $140 million with overall gross margin of 35% and positive Adjusted EBITDA.